These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 22949095)

  • 1. Putative biological mechanisms of efficiency of substrate reduction therapies for mucopolysaccharidoses.
    Banecka-Majkutewicz Z; Jakóbkiewicz-Banecka J; Gabig-Cimińska M; Węgrzyn A; Węgrzyn G
    Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):461-8. PubMed ID: 22949095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses.
    Piotrowska E; Jakóbkiewicz-Banecka J; Barańska S; Tylki-Szymańska A; Czartoryska B; Wegrzyn A; Wegrzyn G
    Eur J Hum Genet; 2006 Jul; 14(7):846-52. PubMed ID: 16670689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression-targeted isoflavone therapy.
    Węgrzyn A
    IUBMB Life; 2012 Apr; 64(4):307-15. PubMed ID: 22362546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative estimation of lysosomal storage in mucopolysaccharidoses by electron microscopy analysis.
    Narajczyk M; Moskot M; Konieczna A
    Acta Biochim Pol; 2012; 59(4):693-6. PubMed ID: 23230565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Principles of therapeutic approaches for mucopolysaccharidoses].
    Caillaud C
    Arch Pediatr; 2014 Jun; 21 Suppl 1():S39-45. PubMed ID: 25063383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate reduction therapies for mucopolysaccharidoses.
    Jakóbkiewicz-Banecka J; Piotrowska E; Gabig-Cimińska M; Borysiewicz E; Słomińska-Wojewódzka M; Narajczyk M; Węgrzyn A; Węgrzyn G
    Curr Pharm Biotechnol; 2011 Nov; 12(11):1860-5. PubMed ID: 21902626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mucopolysaccharidoses--biochemical mechanisms of diseases and therapeutic possibilities].
    Kloska A; Tylki-Szymańska A; Wegrzyn G
    Postepy Biochem; 2011; 57(2):133-47. PubMed ID: 21913414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway.
    Jakóbkiewicz-Banecka J; Piotrowska E; Narajczyk M; Barańska S; Wegrzyn G
    J Biomed Sci; 2009 Mar; 16(1):26. PubMed ID: 19272193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental and behavioral aspects of mucopolysaccharidoses with brain manifestations - Neurological signs and symptoms.
    Shapiro EG; Jones SA; Escolar ML
    Mol Genet Metab; 2017 Dec; 122S():1-7. PubMed ID: 29074036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation of sulfated urinary glycosaminoglycans by high-resolution electrophoresis for isotyping of mucopolysaccharidoses in Malaysia.
    Nor A; Zabedah MY; Norsiah MD; Ngu LH; Suhaila AR
    Malays J Pathol; 2010 Jun; 32(1):35-42. PubMed ID: 20614724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different?
    Węgrzyn G; Jakóbkiewicz-Banecka J; Narajczyk M; Wiśniewski A; Piotrowska E; Gabig-Cimińska M; Kloska A; Słomińska-Wojewódzka M; Korzon-Burakowska A; Węgrzyn A
    Med Hypotheses; 2010 Dec; 75(6):605-9. PubMed ID: 20732748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between severity of mucopolysaccharidoses and combination of the residual enzyme activity and efficiency of glycosaminoglycan synthesis.
    Piotrowska E; Jakóbkiewicz-Banecka J; Tylki-Szymańska A; Czartoryska B; Wegrzyn A; Wegrzyn G
    Acta Paediatr; 2009 Apr; 98(4):743-9. PubMed ID: 19046346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A general model for genetic regulation of turnover of glycosaminoglycans suggests a possible procedure for prediction of severity and clinical progress of mucopolysaccharidoses.
    Wegrzyn G; Wegrzyn A; Tylki-Szymańska A
    Med Hypotheses; 2004; 62(6):986-92. PubMed ID: 15142662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary glycosaminoglycans as a potential biomarker for evaluating treatment efficacy in subjects with mucopolysaccharidoses.
    Kakkis E; Marsden D
    Mol Genet Metab; 2020 May; 130(1):7-15. PubMed ID: 32224020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose genistein aglycone therapy is safe in patients with mucopolysaccharidoses involving the central nervous system.
    Kim KH; Dodsworth C; Paras A; Burton BK
    Mol Genet Metab; 2013 Aug; 109(4):382-5. PubMed ID: 23845234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle disturbances in mucopolysaccharidoses: Transcriptomic and experimental studies on cellular models.
    Brokowska J; Gaffke L; Pierzynowska K; Cyske Z; Węgrzyn G
    Exp Biol Med (Maywood); 2022 Sep; 247(18):1639-1649. PubMed ID: 36000158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for Mucopolysaccharidoses.
    Sawamoto K; Chen HH; Alméciga-Díaz CJ; Mason RW; Tomatsu S
    Mol Genet Metab; 2018 Feb; 123(2):59-68. PubMed ID: 29295764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses.
    Kloska A; Jakóbkiewicz-Banecka J; Narajczyk M; Banecka-Majkutewicz Z; Węgrzyn G
    Metab Brain Dis; 2011 Mar; 26(1):1-8. PubMed ID: 21305347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mucopolysaccharidoses: a success of molecular medicine.
    Clarke LA
    Expert Rev Mol Med; 2008 Jan; 10():e1. PubMed ID: 18201392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adeno-associated viral gene therapy for mucopolysaccharidoses exhibiting neurodegeneration.
    Lau AA; Hemsley KM
    J Mol Med (Berl); 2017 Oct; 95(10):1043-1052. PubMed ID: 28660346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.